Literature DB >> 3115018

Arginine induced growth hormone (hGH) response and paradoxical hGH secretion stimulated by TRH in diabetes mellitus.

G Winkler, L Gerö, T Halmos, A Grósz, G Gefferth, P Varga, G Tamás.   

Abstract

Growth hormone (hGH) reserve following arginine administration and the paradoxical hGH response to thyrotropin-releasing hormone (TRH) were studied in 30 diabetics without evidence of vascular complications. The diabetics were divided into 4 groups according to the type of their disease and to the metabolic condition within the IDDM group (insulin-dependent: IDDM, in acceptable response and in poor metabolic control; non-insulin-dependent: NIDDM, and juvenile diabetics not requiring insulin at least for two years after diagnosing their disease: NIDDY). The results were compared with controls of identical age and normal weight. A paradoxical hGH response to TRH stimulation was found only in IDDM patients in poor metabolic control. In this group the hGH reserve revealed by arginine was significantly larger than in the others. It was shown that the induced hGH release was independent of the sex distribution of the groups and of the basal hGH values. Magnitude of the hGH reserve and appearance of the paradoxical hGH response were not necessarily correlated but the substantial reserve was frequently associated with a paradoxical response. It can be assumed that the unfavorable metabolic condition is of decisive importance in giving rise to these anomalies. Our observations seem to confirm the need for good metabolic control if the pathological hGH secretion in diabetics is to be prevented.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115018     DOI: 10.1007/bf02742849

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  21 in total

1.  In vitro synthesis of hemoglobin AIc.

Authors:  R Flückiger; K H Winterhalter
Journal:  FEBS Lett       Date:  1976-12-01       Impact factor: 4.124

2.  Sex difference in human growth hormone (GH) response to intravenous human pancreatic GH-releasing hormone administration in young adults.

Authors:  A E Smals; G F Pieters; A G Smals; T J Benraad; J Van Laarhoven; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

3.  Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.

Authors:  G Faglia; P Beck-Peccoz; C Ferrari; P Travaglini; B Ambrosi; A Spada
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

4.  The effects of thyrotropin-releasing hormone and luteinizing hormone-releasing hormone on growth hormone release in patients with homozygous beta-thalassaemia.

Authors:  A Masala; T Meloni; D Galisai; S Alagna; P P Rovasio; S Rassu; A F Milia
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

5.  Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

Authors:  K Maeda; Y Kato; N Yamaguchi; K Chihara; S Ohgo
Journal:  Acta Endocrinol (Copenh)       Date:  1976-01

6.  Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism.

Authors:  R Collu; G Leboeuf; J Letarte; J R Ducharme
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

7.  Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).

Authors:  L Gerö; L Korányi; G Tamás
Journal:  Diabete Metab       Date:  1983-09

8.  Metabolism of glomerular basement membrane in normal, hypophysectomized, and growth-hormone-treated diabetic rats.

Authors:  A S Reddi
Journal:  Exp Mol Pathol       Date:  1985-10       Impact factor: 3.362

9.  Diurnal hypersecretion of growth hormone in depression.

Authors:  J Mendlewicz; P Linkowski; M Kerkhofs; D Desmedt; J Golstein; G Copinschi; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

10.  Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.

Authors:  A D Harrower
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

View more
  2 in total

1.  Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Authors:  O Giampietro; M Ferdeghini; R Miccoli; G Gregori; G Penno; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

2.  Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients.

Authors:  U Valentini; A Cimino; A Rotondi; L Rocca; R Pelizzari; A Giustina; C Marchetti; G Romanelli
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.